S&P 500   4,342.61 (+0.29%)
DOW   34,109.08 (+0.11%)
QQQ   359.56 (+0.48%)
AAPL   174.87 (+0.54%)
MSFT   320.19 (+0.21%)
META   302.98 (+2.45%)
GOOGL   131.23 (+0.61%)
AMZN   131.23 (+1.47%)
TSLA   254.30 (-0.55%)
NVDA   415.41 (+1.28%)
NIO   8.60 (+1.78%)
BABA   88.19 (+4.85%)
AMD   96.61 (+0.52%)
T   15.11 (-1.31%)
F   12.57 (+3.03%)
MU   68.73 (+1.22%)
CGC   0.82 (+6.24%)
GE   112.92 (-0.06%)
DIS   82.55 (-0.22%)
AMC   7.78 (+1.04%)
PFE   32.63 (-0.67%)
PYPL   58.71 (+0.15%)
NFLX   381.87 (-0.59%)
S&P 500   4,342.61 (+0.29%)
DOW   34,109.08 (+0.11%)
QQQ   359.56 (+0.48%)
AAPL   174.87 (+0.54%)
MSFT   320.19 (+0.21%)
META   302.98 (+2.45%)
GOOGL   131.23 (+0.61%)
AMZN   131.23 (+1.47%)
TSLA   254.30 (-0.55%)
NVDA   415.41 (+1.28%)
NIO   8.60 (+1.78%)
BABA   88.19 (+4.85%)
AMD   96.61 (+0.52%)
T   15.11 (-1.31%)
F   12.57 (+3.03%)
MU   68.73 (+1.22%)
CGC   0.82 (+6.24%)
GE   112.92 (-0.06%)
DIS   82.55 (-0.22%)
AMC   7.78 (+1.04%)
PFE   32.63 (-0.67%)
PYPL   58.71 (+0.15%)
NFLX   381.87 (-0.59%)
S&P 500   4,342.61 (+0.29%)
DOW   34,109.08 (+0.11%)
QQQ   359.56 (+0.48%)
AAPL   174.87 (+0.54%)
MSFT   320.19 (+0.21%)
META   302.98 (+2.45%)
GOOGL   131.23 (+0.61%)
AMZN   131.23 (+1.47%)
TSLA   254.30 (-0.55%)
NVDA   415.41 (+1.28%)
NIO   8.60 (+1.78%)
BABA   88.19 (+4.85%)
AMD   96.61 (+0.52%)
T   15.11 (-1.31%)
F   12.57 (+3.03%)
MU   68.73 (+1.22%)
CGC   0.82 (+6.24%)
GE   112.92 (-0.06%)
DIS   82.55 (-0.22%)
AMC   7.78 (+1.04%)
PFE   32.63 (-0.67%)
PYPL   58.71 (+0.15%)
NFLX   381.87 (-0.59%)
S&P 500   4,342.61 (+0.29%)
DOW   34,109.08 (+0.11%)
QQQ   359.56 (+0.48%)
AAPL   174.87 (+0.54%)
MSFT   320.19 (+0.21%)
META   302.98 (+2.45%)
GOOGL   131.23 (+0.61%)
AMZN   131.23 (+1.47%)
TSLA   254.30 (-0.55%)
NVDA   415.41 (+1.28%)
NIO   8.60 (+1.78%)
BABA   88.19 (+4.85%)
AMD   96.61 (+0.52%)
T   15.11 (-1.31%)
F   12.57 (+3.03%)
MU   68.73 (+1.22%)
CGC   0.82 (+6.24%)
GE   112.92 (-0.06%)
DIS   82.55 (-0.22%)
AMC   7.78 (+1.04%)
PFE   32.63 (-0.67%)
PYPL   58.71 (+0.15%)
NFLX   381.87 (-0.59%)
NASDAQ:AMTX

Aemetis (AMTX) Stock Forecast, Price & News

$4.19
-0.09 (-2.10%)
(As of 10:04 AM ET)
Compare
Today's Range
$4.19
$4.56
50-Day Range
$4.28
$8.22
52-Week Range
$1.16
$8.99
Volume
65,359 shs
Average Volume
822,151 shs
Market Capitalization
$162.78 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.42

Aemetis MarketRank™ Forecast

Analyst Rating
Hold
2.40 Rating Score
Upside/​Downside
220.2% Upside
$13.42 Price Target
Short Interest
Bearish
12.07% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.35mentions of Aemetis in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$84,750 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.79) to ($0.57) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.77 out of 5 stars

Oils/Energy Sector

204th out of 237 stocks

Industrial Organic Chemicals Industry

14th out of 17 stocks


AMTX stock logo

About Aemetis (NASDAQ:AMTX) Stock

Aemetis, Inc. operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the acquisition, development, and commercialization of negative carbon intensity products and technologies that replace traditional petroleum-based products. In addition, it produces and sells ethanol; and wet distillers grains, distillers corn oil, and condensed distillers solubles to dairies and feedlots as animal feed. Further, the company markets and supplies high-grade alcohol and hand sanitizer. Additionally, it researches and develops conversion technologies using waste feedstocks to produce biofuels and biochemicals. Furthermore, it sells biodiesel primarily to government oil marketing companies, transport companies, resellers, distributors, and private refiners through its own sales force and independent sales agents, as well as to brokers who resell the product to end-users. Aemetis, Inc. was founded in 2005 and is headquartered in Cupertino, California.

AMTX Price History

AMTX Stock News Headlines

Aemetis' (AMTX) Buy Rating Reiterated at HC Wainwright
Aemetis, Inc. (NASDAQ:AMTX) Short Interest Up 20.3% in August
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
Aemetis (NASDAQ:AMTX) Receives Buy Rating from HC Wainwright
H.C. Wainwright Sticks to Its Buy Rating for Aemetis (AMTX)
What 5 Analyst Ratings Have To Say About Aemetis
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
Aemetis Target of Unusually Large Options Trading (NASDAQ:AMTX)
Aemetis (AMTX) Receives a Hold from Truist Financial
Aemetis Inc
4 Analysts Have This to Say About Aemetis
UBS Upgrades Aemetis (AMTX)
Truist Financial Remains a Hold on Aemetis (AMTX)
Aemetis Reports Second Quarter 2023 Financial Results
See More Headlines
Receive AMTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aemetis and its competitors with MarketBeat's FREE daily newsletter.

AMTX Company Calendar

Last Earnings
8/03/2023
Today
9/22/2023
Next Earnings (Estimated)
11/02/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Industrial organic chemicals
Sub-Industry
N/A
Current Symbol
NASDAQ:AMTX
Employees
167
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$13.42
High Stock Price Forecast
$28.00
Low Stock Price Forecast
$2.50
Forecasted Upside/Downside
+220.2%
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
5 Analysts

Profitability

Net Income
$-107,760,000.00
Pretax Margin
-74.85%

Debt

Sales & Book Value

Annual Sales
$256.51 million
Book Value
($5.76) per share

Miscellaneous

Free Float
33,279,000
Market Cap
$162.78 million
Optionable
Not Optionable
Beta
1.38
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Eric A. McAfee (Age 60)
    Co-Founder, Exec. Chairman & CEO
    Comp: $460k
  • Mr. Todd A. WaltzMr. Todd A. Waltz (Age 62)
    Exec. VP & CFO
    Comp: $371k
  • Mr. Andrew B. FosterMr. Andrew B. Foster (Age 58)
    Exec. VP & COO
    Comp: $361.94k
  • Mr. Sanjeev GuptaMr. Sanjeev Gupta (Age 63)
    Exec. VP of Aemetis International
    Comp: $376.25k
  • Mr. J. Michael Rockett
    Exec. VP, Gen. Counsel & Corp. Sec.













AMTX Stock - Frequently Asked Questions

Should I buy or sell Aemetis stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aemetis in the last twelve months. There are currently 1 sell rating, 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" AMTX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AMTX, but not buy additional shares or sell existing shares.
View AMTX analyst ratings
or view top-rated stocks.

What is Aemetis' stock price forecast for 2023?

5 Wall Street research analysts have issued 12-month target prices for Aemetis' stock. Their AMTX share price forecasts range from $2.50 to $28.00. On average, they expect the company's share price to reach $13.42 in the next year. This suggests a possible upside of 220.2% from the stock's current price.
View analysts price targets for AMTX
or view top-rated stocks among Wall Street analysts.

How have AMTX shares performed in 2023?

Aemetis' stock was trading at $3.96 at the start of the year. Since then, AMTX shares have increased by 5.8% and is now trading at $4.19.
View the best growth stocks for 2023 here
.

Are investors shorting Aemetis?

Aemetis saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 4,690,000 shares, an increase of 20.3% from the August 15th total of 3,900,000 shares. Based on an average daily trading volume, of 734,700 shares, the days-to-cover ratio is currently 6.4 days.
View Aemetis' Short Interest
.

When is Aemetis' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023.
View our AMTX earnings forecast
.

How were Aemetis' earnings last quarter?

Aemetis, Inc. (NASDAQ:AMTX) issued its quarterly earnings results on Thursday, August, 3rd. The specialty chemicals company reported ($0.68) earnings per share for the quarter, missing analysts' consensus estimates of ($0.28) by $0.40. The specialty chemicals company earned $45.11 million during the quarter, compared to the consensus estimate of $67.30 million.

What ETF holds Aemetis' stock ?

Invesco Dorsey Wright Energy Momentum ETF holds 189,235 shares of AMTX stock, representing 1.60% of its portfolio.

What other stocks do shareholders of Aemetis own?
What is Aemetis' stock symbol?

Aemetis trades on the NASDAQ under the ticker symbol "AMTX."

Who are Aemetis' major shareholders?

Aemetis' stock is owned by many different institutional and retail investors. Top institutional investors include Encompass Capital Advisors LLC (4.65%), BlackRock Inc. (1.44%), Stifel Financial Corp (1.13%), Geode Capital Management LLC (0.80%), Citadel Advisors LLC (0.00%) and State Street Corp (0.35%). Insiders that own company stock include Andrew B Foster, Andrew B Foster, Francis P Barton, Francis P Barton, John R Block, John R Block, Naomi Louise Boness, Sanjeev Gupta, Timothy Alan Simon and Todd Waltz.
View institutional ownership trends
.

How do I buy shares of Aemetis?

Shares of AMTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Aemetis' stock price today?

One share of AMTX stock can currently be purchased for approximately $4.19.

How much money does Aemetis make?

Aemetis (NASDAQ:AMTX) has a market capitalization of $162.78 million and generates $256.51 million in revenue each year. The specialty chemicals company earns $-107,760,000.00 in net income (profit) each year or ($4.05) on an earnings per share basis.

How many employees does Aemetis have?

The company employs 167 workers across the globe.

How can I contact Aemetis?

Aemetis' mailing address is 20400 STEVENS CREEK BLVD SUITE 700, CUPERTINO CA, 95014. The official website for the company is www.aemetis.com. The specialty chemicals company can be reached via phone at (408) 213-0940, via email at investors@aemetis.com, or via fax at 408-252-8044.

This page (NASDAQ:AMTX) was last updated on 9/22/2023 by MarketBeat.com Staff

My Account -